Full history for every metric is available with a Kvantra account
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $bn | 7 | 8 | 9 | 9 | 10 | 11 | 11 | 11 |
| Operating profit | $bn | 1 | 1 | ||||||
| Net profit | $bn | -1 | 0 | 0 | 1 | 1 | 1 | 1 | 2 |
| EPS reported | $ | 2.07 | 1.29 | ||||||
| Operating cashflow per share | $ | 4.82 | 4.68 | ||||||
| Capex per share | $ | 1.15 | 1.22 | ||||||
| FCF per share | $ | 3.67 | 3.46 | ||||||
| Free cash flow | $bn | 2 | 2 | ||||||
| Net debt | $bn | 4 | 4 | ||||||
| Book value equity | $bn | 22 | 22 | ||||||
| Book value per share | $ | 44.38 | 44.31 | ||||||
| Number of shares | m | 496.2 | 488.7 | ||||||
| DPS (TTM paid) | $ | 0.36 | 0.36 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 38.56 | 51.46 | ||||||
| P/B LTM | x | 1.79 | 1.44 | ||||||
| P/S LTM | x | 3.61 | 2.89 | ||||||
| P/FCF LTM | x | 21.75 | 18.22 | ||||||
| EV/EBITDA LTM | x | 15.67 | 15.02 | ||||||
| EV/Sales LTM | x | 3.99 | 3.25 | ||||||
| Earnings Yield LTM | % | 2.59% | 1.94% | ||||||
| FCF Yield | % | 4.60% | 5.49% | ||||||
| Quality | |||||||||
| ROE | % | 4.66% | 2.91% | ||||||
| ROIC | % | 4.12% | 3.24% | ||||||
| Operating margin | % | 13.08% | 9.87% | ||||||
| Gross margin | % | 55.24% | 56.45% | ||||||
| FCF/Sales | % | 16.61% | 15.57% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | +0.98% | -40.00% | ||||||
| Sales Growth YoY | % | +9.94% | +7.48% | ||||||
| Net Income Growth YoY | % | +0.85% | -40.29% | ||||||
| FCF Growth | % | +28.66% | +5.82% | ||||||
| Operating Profit Growth | % | +0.83% | -23.40% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.44% | 0.56% | ||||||
| Dividend Growth | % | +7.31% | +7.31% | ||||||
| Payout Ratio | % | 16.93% | 27.82% | ||||||
| FCF/Debt | x | 0.32 | 0.32 | ||||||
| Net Debt/EBITDA | x | 1.49 | 1.95 | ||||||
| EBIT/Net interest | x | 6.67 | 5.13 | ||||||
| Net debt/market cap | % | 9.03% | 12.36% | ||||||
| Net debt/Equity | x | 0.16 | 0.18 | ||||||
| Gross debt/equity | x | 0.26 | 0.25 | ||||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Alcon Inc. is a global eye care enterprise dedicated to the research, development, manufacturing, and distribution of a comprehensive range of vision products for both eye care professionals and their patients worldwide. The company operates through two primary divisions. Its Surgical segment equips ophthalmic surgeons with advanced solutions for various procedures. This includes specialized equipment, diagnostic instrumentation, and implantable devices such as intraocular lenses (IOLs), alongside a full suite of consumables like viscoelastic substances, surgical solutions, and customized procedure kits. For cataract interventions, key offerings feature the Centurion Vision System, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA System for intra-operative measurements. Vitreoretinal surgeons benefit from systems like Constellation Vision, procedure packs, lasers, and a variety of specialized micro-instruments, including grieshaber and MIVS tools, scissors, forceps, medical-grade vitreous tamponades, and Hypervit vitrectomy probes. Refractive surgery innovations include WaveLight lasers and Contoura Vision for LASIK treatments, and the segment also provides the EX-PRESS glaucoma filtration device. Its IOL portfolio, prominently featuring AcrySof IQ, includes advanced technology lenses like PanOptix and ReSTOR, designed to correct presbyopia and astigmatism during cataract removal. The Vision Care segment addresses everyday eye health needs. It offers a diverse selection of contact lenses, including daily disposables, reusable options, and color-enhancing varieties. This segment also provides ocular health products for conditions such as dry eye, glaucoma, and allergies, in addition to contact lens care solutions, ocular vitamins, and redness-relieving drops. Prominent brands within this segment include TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux. Founded in 1945, the company was initially known as Alcon Universal S.A. before rebranding as Alcon Inc. in December 2001. Its headquarters are located in Geneva, Switzerland.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Based on consensus from external analysts. Not Kvantra's opinion.
Alcon Inc. is a global eye care enterprise dedicated to the research, development, manufacturing, and distribution of a comprehensive range of vision products for both eye care professionals and their patients worldwide. The company operates through two primary divisions. Its Surgical segment equips ophthalmic surgeons with advanced solutions for various procedures. This includes specialized equipment, diagnostic instrumentation, and implantable devices such as intraocular lenses (IOLs), alongside a full suite of consumables like viscoelastic substances, surgical solutions, and customized procedure kits. For cataract interventions, key offerings feature the Centurion Vision System, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA System for intra-operative measurements. Vitreoretinal surgeons benefit from systems like Constellation Vision, procedure packs, lasers, and a variety of specialized micro-instruments, including grieshaber and MIVS tools, scissors, forceps, medical-grade vitreous tamponades, and Hypervit vitrectomy probes. Refractive surgery innovations include WaveLight lasers and Contoura Vision for LASIK treatments, and the segment also provides the EX-PRESS glaucoma filtration device. Its IOL portfolio, prominently featuring AcrySof IQ, includes advanced technology lenses like PanOptix and ReSTOR, designed to correct presbyopia and astigmatism during cataract removal. The Vision Care segment addresses everyday eye health needs. It offers a diverse selection of contact lenses, including daily disposables, reusable options, and color-enhancing varieties. This segment also provides ocular health products for conditions such as dry eye, glaucoma, and allergies, in addition to contact lens care solutions, ocular vitamins, and redness-relieving drops. Prominent brands within this segment include TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux. Founded in 1945, the company was initially known as Alcon Universal S.A. before rebranding as Alcon Inc. in December 2001. Its headquarters are located in Geneva, Switzerland.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free